When you use our sites, PAREXEL will assign cookie files (“Cookies”) to you, which are a small amount of information we send to your web browser. Cookies enable the computers operating our websites to differentiate between visitors and to track the patterns of activities engaged in by different visitors. By clicking the Continue Browsing button, you agree to accept the PAREXEL Privacy Policy and all Cookies deployed on this site. You may choose to continue browsing with cookies, or leave the site.

Skip to main content

Solutions
Expertise
Company
Trials

China
Japan

Solutions
Expertise
Company
Trials

China
Japan

Solutions
Innovations & Therapeutic Expertise
Volunteers, Studies & Investigators
Ecosystem, Education & Careers
News, Events & Resources
About Us
Careers

Solutions
Expertise
Patient Stories
Trials
Resources
News & Events
COVID-19
Company
Careers

China
Japan

Get Personalized Email Content

Global Locations

275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300

2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170

^© 2000-2021. Parexel International Corporation.

Solutions Overview
Clinical Development
Outsourcing Services

Parexel^® Biotech
Consulting
Medical Affairs
Real-World Evidence and Late Phase

Solutions by Industry
- Pharma Solutions
- Medical Devices
Solutions by Development Phase

Overview
Patient Centricity
Precision Medicine
Adaptive & Flexible Trials
Real World Evidence
The Innovation Imperative
Our Experts

Therapeutic Areas

Overview
T.J.'s Story
Tina's Story
Dayson & Erika's Story
Paul's Story
Monica's Story

Rob's Story
Yasmeem's Story
Anisha's Story
Sara's Story
Stacy's Story

Trial Volunteer Overview
Investigators
- Clinical Trial Investigator Sign-Up

Global Study Locations

Parexel Resource Center
Parexel Insights Blog
Podcasts
Drug Innovation
Our Experts
Parexel Academy
Your Preferences

Social Channels
- LinkedIn
- Facebook
- Twitter
- YouTube

Parexel Newsroom
Events and Webinars

Long COVID Syndrome Program
COVID-19 Response

COVID-19 Resource Center
COVID Clearinghouse Data Platform

Our Company
Leadership Team
Our DE&I Strategy
- Discussions in Diversity
Suppliers
Career Opportunities
- Find Your Career Path
Trust & Privacy
Environmental, Social, & Governance (ESG)
External Support Center

Compliance & Ethics
Global Locations
Partners
Contact Us

Career Opportunities
- Find Your Career Path

Biotech Resources

Browse our Biotech resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Parexel Biotech

Home
Latest Content
About Us

Recent Searches

Home
Oncology Drug Development
Crafting an early genomics strategy in oncology drug development

Crafting an early genomics strategy in oncology drug development

Discover three key considerations for crafting a successful genomic biomarker strategy in this article.

Loading, please wait

Error - something went wrong!

Let's start a conversation...

Thank you! We'll be in touch soon.

Previous Article

101 guide for real-world evidence

We have created this guide to simplify the terminology of real-world evidence (RWE) and outline some of the strategic options available.
Next Flipbook

Top ten rules for success in decentralized trials

In this article, we summarize what we’ve learned and outline the top 10 rules for a successful DCT.

Other content in this Stream

New endpoints for early-stage cancer are gaining regulatory traction

Read More
Five lessons for building an external control arm that regulators can use

Read More
How to accelerate oncology clinical trials through site relationships and patient insights

Learn how all stakeholders benefit when patients and their insights are at the heart of every aspect of clinical development.

Read More
Tips for building your oncology reimbursement strategy

In this infographic, we share five tips for building an effective reimbursement strategy for your oncology product.

Learn More
101 guide for real-world evidence

We have created this guide to simplify the terminology of real-world evidence (RWE) and outline some of the strategic options available.

Learn More
Top ten rules for success in decentralized trials

In this article, we summarize what we’ve learned and outline the top 10 rules for a successful DCT.

Read More
We need faster endpoints for targeted cancer drugs, and there is one

As a former regulator, Jorge shares his perspectives for the need of more faster endpoints to measure how targeted cancer drugs can benefit patients. He believes it can be created by combining two...

Learn More
Three risk management strategies for expedited approvals

Three risk management strategies for drug developers who wish to take full advantage of expedited pathways to achieve reimbursable innovation for the benefit of patients.

Watch Video
Impact of COVID-19 on Drug Development in Rare Disease and Oncology

Key findings from a recent discussion with Parexel regulatory experts and the rare disease patient advocacy group Sara’s Cure.

Read More
Leveraging Real-world Evidence in a Rare Disease Oncology Drug Approval

Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-world Evidence and FDA/Regulatory expertise to develop and execute a Synthet

Watch Video
Parexel Biotech: The value of patient-centric approaches - escaping the clinic

Parexel’s Rosamund Round, Director, Patient Innovation Center and Amy McKee, Vice President, Regulatory Consulting Services sit down with Monica Theis, a breast cancer survivor and two-time clinical t

Watch Video
Whitepaper: COVID-19 Vaccination in Cancer Patients

In this whitepaper, we address the unique variables, optimal timing, and immunogenic considerations for vaccinating individuals with cancer.

Read More
Top 10 Myths About Working with the FDA for an Oncology Drug Approval

Among biotech companies, a primary concern is how to establish a clinical strategy for scientific and commercial success at the earliest stage. In that respect, regulatory considerations figure...

Learn More
On-demand webinar: Roadmap for Oncology Drug Development

Insights on regulatory and trial design considerations for drug development in oncology.

Learn More
Crafting a genomics strategy early is key for successful oncology drug development

Discover three key considerations for crafting a successful genomic biomarker strategy in this article.

Read More
Infographic: Top 10 myths about working with FDA for oncology drug approval

Amy McKee, VP of Regulatory Consulting for Parexel and former Deputy Director of the FDA Oncology Center of Excellence, shares valuable insights about knowing when and how to engage with regulators.

Read More
The Parexel Podcast | Episode 12: ASCO20 Debrief: The latest in cell and gene therapy

In 2020, ASCO went virtual for the first time. While the format was different, one thing was clear: despite all that is happening in the world, there are still many patients in need. Todd Shuster,...

Learn More
The future of clinical trials is now: Decentralized Clinical Trials

Parexel’s Decentralized Clinical Trials represent an opportunity to rethink and refresh how research studies are conducted.

Read More
Reflections on Cancer Drug Development Strategies with Newly-Introduced Chinese Regulations

The global cancer drug market is set to maintain strong growth over the next decade due to factors such as environmental pollution, population aging, and poor lifestyles that leave...

Learn More

Return to Home

© Parexel International LLC

CORPORATE LINKS
About Us
News
Events
Careers
Education
Investigators
My Preferences
Global Locations

SOLUTIONS
Parexel Biotech
Clinical Development
Consulting
Medical Affairs
Real-World Evidence
FSP

STUDIES & VOLUNTEERS
About Trials
Participate in a Trial
GLOBAL STUDY LOCATIONS
Baltimore, US
Los Angeles, US
London, UK
Berlin, DE

275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300

2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170

© 2021-2022. Parexel International Corporation. All Rights Reserved.

Privacy Policy
Terms of Service
Modern Slavery Statement Act

--> --> --> -->